1 Result(s)

Article

Prothymosin α and a prothymosin α-derived peptide enhance T_H1-type immune responses against defined HER-2/neu epitopes

Active cancer immunotherapies are beginning to yield clinical benefit, especially those using peptide-pulsed dendritic cells (DCs). Different adjuvants, including Toll-like receptor (TLR) agonists, commonly co...

Kyriaki Ioannou, Evelyna Derhovanessian, Eleni Tsakiri, Pinelopi Samara… in BMC Immunology (2013)